These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 1884479)
21. Ability of dipyridamole-thallium-201 imaging one to four days after acute myocardial infarction to predict in-hospital and late recurrent myocardial ischemic events. Brown KA; O'Meara J; Chambers CE; Plante DA Am J Cardiol; 1990 Jan; 65(3):160-7. PubMed ID: 2296884 [TBL] [Abstract][Full Text] [Related]
22. Prognosis following interventional therapy for acute myocardial infarction: utility of dipyridamole thallium scintigraphy. Hendel RC; Gore JM; Alpert JS; Leppo JA Cardiology; 1991; 79(1):73-80. PubMed ID: 1777916 [TBL] [Abstract][Full Text] [Related]
23. Safety and clinical utility of combined intravenous dipyridamole/symptom-limited exercise stress test with thallium-201 imaging in patients with known or suspected coronary artery disease. Ignaszewski AP; McCormick LX; Heslip PG; McEwan AJ; Humen DP J Nucl Med; 1993 Dec; 34(12):2053-61. PubMed ID: 8254386 [TBL] [Abstract][Full Text] [Related]
24. [Comparison of exercise thallium-201 perfusion scintigraphy and coronarography in the prognostic stratification of patients with post-infarction residual ischemia]. Dalle Mule J; Soravia G; Da Rold A; Pellegrini P; Perelli R; Martinelli F; Sponga B; Burelli C; Zanuttini D G Ital Cardiol; 1991 Sep; 21(9):939-55. PubMed ID: 1790832 [TBL] [Abstract][Full Text] [Related]
25. Dipyridamole-thallium 201 scintigraphy in the early post-infarction period. (Safety and accuracy in predicting the extent of coronary disease and future recurrence of angina in patients suffering from their first myocardial infarction). Pirelli S; Inglese E; Suppa M; Corrada E; Campolo L Eur Heart J; 1988 Dec; 9(12):1324-31. PubMed ID: 3229427 [TBL] [Abstract][Full Text] [Related]
26. Dipyridamole thallium-201 imaging very early after uncomplicated acute myocardial infarction in patients treated with thrombolytic therapy. Pirelli S; Moreo A; Piccalo G; Corato A; Sara R; Danzi GB; Corrada E; Massa D; De Vita C Eur Heart J; 1997 Jun; 18(6):925-30. PubMed ID: 9183583 [TBL] [Abstract][Full Text] [Related]
28. Assessing prognosis after acute myocardial infarction in the thrombolytic era. Gimple LW; Beller GA J Nucl Cardiol; 1994; 1(2 Pt 1):198-209. PubMed ID: 9420687 [TBL] [Abstract][Full Text] [Related]
29. Comparison of myocardial ischaemia in post-infarction patients with and without angina: assessment by dipyridamole 201T1 imaging. Yang CC; Chen UW; Huang YF; Lee BF; Jong SB Nucl Med Commun; 1995 Aug; 16(8):647-54. PubMed ID: 7491176 [TBL] [Abstract][Full Text] [Related]
30. Prognostic impact of stress testing in coronary artery disease. Severi S; Michelassi C Circulation; 1991 May; 83(5 Suppl):III82-8. PubMed ID: 2022053 [TBL] [Abstract][Full Text] [Related]
31. [Prognostic stratification of non complicated acute myocardial infarct. Usefulness of the dipyridamole test with ecg-echo-thallium 201]. Passoni F; D'Urbano M; Castelli C; Cafiero F; Seveso G; Spaziani D; Cammelli F; Romano S G Ital Cardiol; 1991 May; 21(5):477-84. PubMed ID: 1936751 [TBL] [Abstract][Full Text] [Related]
32. Myocardial 201Tl washout after combined dipyridamole submaximal exercise stress: reference values from different patient groups. Fridrich L Eur J Nucl Med; 1989; 15(2):81-6. PubMed ID: 2920742 [TBL] [Abstract][Full Text] [Related]
33. Physiological assessment of sensitivity of noninvasive testing for coronary artery disease. Simonetti I; Rezai K; Rossen JD; Winniford MD; Talman CL; Hollenberg M; Kirchner PT; Marcus ML Circulation; 1991 May; 83(5 Suppl):III43-9. PubMed ID: 2022047 [TBL] [Abstract][Full Text] [Related]